Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study

PURPOSE: Pseudo-progression (PsPD) is a rare phenomenon observed in <5% of cases of non-small cell lung cancer (NSCLC). This event is challenging for both clinicians and patients. Viable biomarkers to distinguish between PsPD and true progressive disease (TPD) are lacking. The aim of our study wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Katsurada, Naoko, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6897378/
https://ncbi.nlm.nih.gov/pubmed/31819535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S228138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados